NSE: FLUOROCHEM | BSE: 542812

Mid-range Performer

Download real time

3400.00 -10.40 (-0.30%)

30.34% Fall from 52W High

2,834 NSE+BSE Volume

NSE 03 Sep, 2025 9:24 AM (IST)

37,349

Market Cap

High in industry

0.7

Beta 1Year

Very Low volatility

Gujarat Fluorochemicals Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for FLUOROCHEM, BSE:542812 Gujarat Fluorochemicals Ltd.

Gujarat Fluorochemicals Ltd.

22 Feb 2025

3400.00

-0.30%

At the cusp of inflection in earnings growth

Buy: Gujarat Fluorochemicals Ltd.

Target

ICICI Securities Limited

Gujarat Fluorochemicals (GFL) is at the cusp of inflection in earnings growth with revenue / EBITDA / PAT CAGR estimated at 20.4%/ 33.4%/ 46% over FY25-27E.

Gujarat Fluorochemic.. has an average target of 3846.67 from 3 brokers.

Gujarat Fluorochemicals Ltd.

29 Jan 2025

3400.00

-0.30%

GUJARAT FLUOROCHEMIC

Sell: Gujarat Fluorochemicals Ltd.

Target

Prabhudas Lilladhar

Gujarat Fluorochemicals Ltd. is trading below all available SMAs

Gujarat Fluorochemicals Ltd.

02 Dec 2024, 12:00AM

3400.00

-0.30%

Analyst Meet update: Aggressive guidance; we await visible rampup in EV entity

Sell: Gujarat Fluorochemicals Ltd.

Target

Emkay

GFL highlighted its growth plans at the group level under InoxGFL group which include the chemicals and wind energy businesses. Management expects the group’s EBITDA to quadruple over coming 3 years led by ramp up in both, battery chemicals and renewable energy businesses.

Gujarat Fluorochemicals Ltd. is trading below all available SMAs

Gujarat Fluorochemicals Ltd.

08 May 2024

3400.00

-0.30%

Gujarat Fluorochemicals

Buy: Gujarat Fluorochemicals Ltd.

ICICI Direct

Gujarat Fluorochemic.. has an average target of 3846.67 from 3 brokers.

Gujarat Fluorochemicals Ltd.

07 May 2024

3400.00

-0.30%

Farfetched guidance and modest recovery; maintain SELL

Sell: Gujarat Fluorochemicals Ltd.

Emkay

GFL’s Q4 EBITDA fell 54% YoY to Rs2.4bn (+15% QoQ) on sluggish
performance in the bulk and fluorochemicals businesses. Fluoropolymers
business is seeing sequential recovery in volumes on a lower base.

Gujarat Fluorochemic.. has an average target of 3846.67 from 3 brokers.

Gujarat Fluorochemicals Ltd.

07 May 2024

3400.00

-0.30%

GUJARAT FLUOROCHEMIC

Sell: Gujarat Fluorochemicals Ltd.

Prabhudas Lilladhar

Promoters unpledged 0.65% of shares in last quarter. Total pledge stands at 0.71% of promoter holdings

Gujarat Fluorochemicals Ltd.

05 Nov 2023

3400.00

-0.30%

Near-term challenges outscoring fluoropolymer opportunity!

Buy: Gujarat Fluorochemicals Ltd.

Target

ICICI Securities Limited

Gujarat Fluorochemicals’ (GFL) Q2FY24 EBITDA at INR 1.6bn and EBITDA margin at 17.2% indicate dismal performance. Earnings were impacted by compression in gross margin, and lower absorption of fixed cost. However, we continue to like its business on two counts – 1) rising opportunity in fluoropolymers where change in industry structure can provide huge benefits for GFL; and 2) battery solutions where company is planning to cater demand of 30-40% cell producers with integrated electrolyte facility, cathode active material and PVDF blinder.

Gujarat Fluorochemicals Ltd. is trading below all available SMAs

Gujarat Fluorochemicals Ltd.

08 Aug 2023

3400.00

-0.30%

Fluoropolymer prices stable; demand weak on destocking

Buy: Gujarat Fluorochemicals Ltd.

Target

ICICI Securities Limited

Gujarat Fluorochemicals’ (GFL) Q1FY24 EBITDA at INR 3.5bn was down 24% YoY. It was impacted by: 1) lower realisation for bulk chemicals where entire revenue loss flows down to PBT, and 2) lower fluoropolymers volumes which led to under-absorption of fixed costs.

Gujarat Fluorochemic.. has an average target of 3846.67 from 3 brokers.

Gujarat Fluorochemicals Ltd.

06 May 2023

3400.00

-0.30%

New-age industries to drive growth

Buy: Gujarat Fluorochemicals Ltd.

Target

ICICI Securities Limited

Gujarat Fluorochemicals’ (GFL) Q4FY23 EBITDA at Rs5.3bn, up 60% YoY, was broadly in line with our estimates and was impacted by lower realisation across businesses – bulk chemicals, ref-gas and fluoropolymers. Revenue / EBITDA benefited from rise in volumes for R-125, and new fluoropolymers.